Scott Fidel

Benjamin Hendrix

David Macdonald

Jason Cassorla

Tao Qiu

Calvin Sternick

- PACS Group received an extension from the NYSE until **November 19, 2025**, to complete the restatement of its financial statements for the three months ended March 31, 2024, and the three and six months ended June 30, 2024, to regain compliance with NYSE listing standards.  **[2001184_0002001184-25-000047_pacsnyselistingextensionpr.htm:0]** 
- The company expects to report **record revenue and Adjusted EBITDA** for the first six months of **2025**.  **[2001184_0002001184-25-000047_pacsnyselistingextensionpr.htm:0]** 
- As of **June 30, 2025**, PACS Group's subsidiaries operated **316 healthcare facilities** across **17 states**, with total facilities occupancy at **88.9%**.  **[2001184_0002001184-25-000047_pacsnyselistingextensionpr.htm:0]** **[2001184_0002001184-25-000047_pacsnyselistingextensionpr.htm:1]** 
- Cash and cash equivalents increased to **$294.2 million** as of **June 30, 2025**, compared to **$157.7 million** as of December 31, 2024.  **[2001184_0002001184-25-000047_pacsnyselistingextensionpr.htm:0]** 
- **Mark Hancock** was appointed **interim Chief Financial Officer** on **September 3, 2025**.  **[2001184_0002001184-25-000047_pacsnyselistingextensionpr.htm:1]**

PACS Group (PACS)